Clinical Genetics and Screening for Idiopathic Pulmonary Fibrosis

Not yet recruitingOBSERVATIONAL
Enrollment

600

Participants

Timeline

Start Date

September 1, 2024

Primary Completion Date

September 1, 2026

Study Completion Date

September 1, 2026

Conditions
Familial Pulmonary FibrosisIdiopathic Pulmonary Fibrosis
Interventions
DIAGNOSTIC_TEST

High resolution Computed Tomography (HRCT) scans of the Chest

A chest high-resolution computed tomography (HRCT) scan will be performed

DIAGNOSTIC_TEST

Pulmonary Function Testing (PFTs)

Spirometry and diffusing capacity of the lung for carbon monoxide (DLCO) measurements will be performed

DIAGNOSTIC_TEST

Digital lung sounds auscultation

Lung sounds will be recorded using a manual approach with a digital stethoscope

DIAGNOSTIC_TEST

Laboratory Assessments

Clinical laboratory tests will be collected from each participant

GENETIC

DNA sequencing

A sample of genomic DNA from peripheral blood lymphocytes will be collected for DNA sequencing

All Listed Sponsors
lead

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

OTHER

NCT06521125 - Clinical Genetics and Screening for Idiopathic Pulmonary Fibrosis | Biotech Hunter | Biotech Hunter